BenevolentAI SA
AEX:BAI

Watchlist Manager
BenevolentAI SA Logo
BenevolentAI SA
AEX:BAI
Watchlist
Price: 0.081 EUR Market Closed
Market Cap: 11.6m EUR

Relative Value

The Relative Value of one BAI stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.081 EUR, BenevolentAI SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BAI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
51
Median 3Y
2
Median 5Y
0
Industry
2.5
Forward
0.6
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
0
Industry
21.8
Forward
-0.2
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
0
Industry
16.6
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
0
Industry
24
vs History
65
vs Industry
81
Median 3Y
1.1
Median 5Y
0.9
Industry
2.1
vs History
vs Industry
91
Median 3Y
-5
Median 5Y
0
Industry
2.7
Forward
-1.5
vs History
7
vs Industry
6
Median 3Y
0
Median 5Y
0
Industry
5.3
vs History
7
vs Industry
55
Median 3Y
-1
Median 5Y
0
Industry
12.8
Forward
0.5
vs History
7
vs Industry
52
Median 3Y
-1
Median 5Y
0
Industry
16.2
Forward
0.4
vs History
7
vs Industry
55
Median 3Y
-1.3
Median 5Y
0
Industry
15.1
vs History
7
vs Industry
42
Median 3Y
-1.3
Median 5Y
0
Industry
17.7
vs History
vs Industry
85
Median 3Y
0.8
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

BAI Competitors Multiples
BenevolentAI SA Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
BenevolentAI SA
AEX:BAI
11.6m EUR 2.1 -0.2 0.4 0.4
US
Eli Lilly and Co
NYSE:LLY
739.9B USD 15.1 66.6 35.8 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
375.3B USD 4.2 17.2 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.6 19.1 13.3 15.2
CH
Roche Holding AG
SIX:ROG
206.8B CHF 3.4 25 9.4 11
CH
Novartis AG
SIX:NOVN
192.2B CHF 4.5 18.8 11.1 14.8
UK
AstraZeneca PLC
LSE:AZN
160.3B GBP 4 28.2 130.8 197.2
US
Merck & Co Inc
NYSE:MRK
203.6B USD 3.2 11.7 8.7 10.5
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
144.3B USD 2.3 18.3 7.8 10.9
P/E Multiple
Earnings Growth PEG
UK
BenevolentAI SA
AEX:BAI
Average P/E: 25.6
Negative Multiple: -0.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.6
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.1
18%
1.1
CH
Roche Holding AG
SIX:ROG
25
32%
0.8
CH
Novartis AG
SIX:NOVN
18.8
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.2
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.7
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.3
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
BenevolentAI SA
AEX:BAI
Average EV/EBITDA: 394.3
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.8
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
11.1
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.8
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
BenevolentAI SA
AEX:BAI
Average EV/EBIT: 1 697.6
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15.2
14%
1.1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
14.8
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.2
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.5
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.9
10%
1.1